Rapid Micro Biosystems is a life sciences technology company providing automation solutions to facilitate the manufacturing and healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Co.'s primary product Growth Direct platform automates the antiquated, manual microbial quality control, testing workflows used in the pharmaceutical manufacturing operations across the globe. The RPID stock yearly return is shown above.
The yearly return on the RPID stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2022 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the RPID annual return calculation with any dividends reinvested as applicable (on ex-dates).
|